Nirman Agri Genetics Ltd
₹ 206
4.98%
01 Apr
- close price
About
Incorporated in 2020, Nirman Agri Genetics Ltd is in the business of manufacturing and processing seeds[1]
Key Points
- Market Cap ₹ 165 Cr.
- Current Price ₹ 206
- High / Low ₹ 484 / 164
- Stock P/E 7.68
- Book Value ₹ 123
- Dividend Yield 0.97 %
- ROCE 33.8 %
- ROE 32.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.1%
Cons
- Promoter holding has decreased over last quarter: -8.24%
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Miscellaneous
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|
| 4 | 13 | 29 | 63 | 194 | |
| 4 | 10 | 24 | 52 | 171 | |
| Operating Profit | 0 | 3 | 4 | 11 | 23 |
| OPM % | 2% | 25% | 15% | 18% | 12% |
| -0 | -0 | -0 | -0 | 0 | |
| Interest | -0 | -0 | 0 | 0 | 0 |
| Depreciation | -0 | -0 | 0 | 0 | 1 |
| Profit before tax | 0 | 3 | 4 | 11 | 22 |
| Tax % | 29% | 25% | 6% | 5% | |
| 0 | 3 | 4 | 10 | 22 | |
| EPS in Rs | 5.01 | 13.00 | 26.90 | ||
| Dividend Payout % | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 155% |
| TTM: | 121% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 493% |
| TTM: | 159% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| Last Year: | 32% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 6 | 6 | 8 |
| Reserves | 0 | 3 | 21 | 31 | 90 |
| 1 | 1 | 1 | 1 | 1 | |
| 1 | 2 | 2 | 6 | 4 | |
| Total Liabilities | 2 | 6 | 30 | 44 | 103 |
| -0 | 0 | 1 | 0 | 3 | |
| CWIP | -0 | -0 | -0 | -0 | -0 |
| Investments | -0 | -0 | 0 | 0 | 0 |
| 2 | 6 | 29 | 44 | 101 | |
| Total Assets | 2 | 6 | 30 | 44 | 103 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -0 | 0 | 0 | 5 | |
| -0 | -0 | -21 | -2 | |
| 1 | 0 | 20 | -1 | |
| Net Cash Flow | 1 | 0 | -1 | 1 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 58 | 114 | 52 | 67 |
| Inventory Days | 21 | 25 | 76 | 61 |
| Days Payable | 40 | 38 | 6 | 39 |
| Cash Conversion Cycle | 39 | 101 | 121 | 89 |
| Working Capital Days | 32 | 81 | 91 | 79 |
| ROCE % | 133% | 27% | 34% |
Documents
Announcements
-
Trading Window-XBRL
29 March 2025 - NIRMAN AGRI GENETICS LIMITED has informed about Closure of Trading Window
-
Trading Window
29 March 2025 - Nirman Agri Genetics Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 March 2025 - Nirman Agri Genetics Limited has informed about Transcript
-
Analysts/Institutional Investor Meet/Con. Call Updates
19 February 2025 - Nirman Agri Genetics Limited has informed about Schedule of meet
-
Updates
19 February 2025 - Nirman Agri Genetics Limited has informed regarding 'Disclosures under Regulation 30 of the SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 (the SEBI Listing Regulations ).'.
Business Overview:[1]
a) NAGL is an agricultural input company that produces, processes, and markets premium hybrid seeds, organic fertilizers, and bio-organic seeds for a variety of crops, including corn, sunflower, cotton, rice, sorghum, and grain.
b) It has recently started producing micronutrients and bioproducts.
c) In addition, it grows non-hybrid seeds.
d) Company is working towards creating seeds with greater yield potential, drought resistance, pest and disease tolerance, etc.
e) It is also working on research and development projects about better breeding techniques and biotechnology instruments, which allows it to create hybrid seeds, micronutrients, and bioproducts.